Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  CareDx Inc    CDNA

CAREDX INC

(CDNA)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

CDNA INVESTIGATION ALERT: Bernstein Liebhard LLP Announces Investigation of CareDx Inc.-- CDNA

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/17/2019 | 03:19pm EDT

NEW YORK, July 17, 2019 /PRNewswire/ -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, is investigating potential securities fraud claims on behalf of shareholders of CareDx Inc. ("CareDx" or the "Company") (NASDAQ: CDNA) resulting from allegations that CareDx and/or its executives may have issued materially misleading information to the investing public.

Bernstein Liebhard LLP.  (PRNewsFoto/Bernstein Liebhard LLP) (PRNewsfoto/Bernstein Liebhard LLP)

If you purchased CareDx securities, and/or would like to discuss your legal rights and options please visit CareDx CDNA Shareholder Investigation or contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com.

In 2017, CareDx launched its AlloSure product for kidney transplant recipients. AlloSure is designed to check for cell-free DNA associated with organ rejection, a serious problem with kidney transplants. AlloSure is currently responsible for 83% of CareDx's total revenue.

On July 16, 2019, a report from Kerrisdale Capital Management noted that the AlloSure test manufactured by CareDx isn't nearly as popular as it seems because it misses around 40% of organ rejections compared to the current standard of care.

On this news, shares of CareDx dropped $4.83, or nearly 13%.

If you purchased CDNA securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/caredxinc-cdna-shareholder-lawsuit-class-action-fraud-stock-153/ or contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com.

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for ten consecutive years.

ATTORNEY ADVERTISING. © 2019 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information
Matthew E. Guarnero
Bernstein Liebhard LLP
https://www.bernlieb.com
(877) 779-1414
MGuarnero@bernlieb.com 

 

Cision
View original content to download multimedia:http://www.prnewswire.com/news-releases/cdna-investigation-alert-bernstein-liebhard-llp-announces-investigation-of-caredx-inc-cdna-300886814.html

SOURCE Bernstein Liebhard LLP


© PRNewswire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CAREDX INC
08/22AlloSure for Heart Transplant Patients Receives CMS Draft Coverage
GL
08/21CAREDX : Fear of Rejection is Transplant Patient's Top Concern
AQ
08/03Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against ..
BU
08/01CAREDX : 2Q Earnings Snapshot
AQ
08/01CAREDX : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
08/01CAREDX, INC. : Results of Operations and Financial Condition, Financial Statemen..
AQ
08/01CareDx Reports Second Quarter 2019 Results
GL
07/24CAREDX Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceedin..
PR
07/22GLANCY PRONGAY & MURRAY LLP : Continues Investigation on Behalf of CareDx, Inc. ..
BU
07/22Law Offices of Howard G. Smith Continues Investigation on Behalf of CareDx, I..
BU
More news